Alfonso Urbanucci

14PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AcceleratorsMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 16, 2026
Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells.

|Aug 22, 2026
IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

|Aug 21, 2026
Epithelial interferon-stimulated gene programs modulate chemotherapy sensitivity in colorectal cancer via EPSTI1.

|Jul 22, 2025
Combination of PSMA targeting alpha-emitting radioligand [212Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer models.

Rugile Liukaityte, Vilde Yuli Stenberg, Andrius Kleinauskas

|Nov 16, 2024
Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer.

Antti Kiviaho, Sini K Eerola, Heini M L Kallio

|Sep 08, 2024
Patient-derived acellular ascites fluid affects drug responses in ovarian cancer cell lines through the activation of key signalling pathways.

Katharina Bischof, Andrea Cremaschi, Lena Eroukhmanoff

Pageof 3

Frequent Collaborators

4 joint publications

Matti Nykter

3 joint publications

Ian G Mills

3 joint publications

Frank Claessens

2 joint publications

Sinja Taavitsainen